Maxalt-mlt and Avelox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt-mlt (rizatriptan benzoate) and Avelox (moxifloxacin hydrochloride). Common drug interactions include arthralgia among females and angiofibroma among males.

The phase IV clinical study analyzes what interactions people have when they take Maxalt-mlt and Avelox. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt-mlt?

Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.

What is Avelox?

Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.



On Aug, 04, 2026

30 people who take Maxalt-mlt and Avelox together, and have interactions are studied.

Maxalt-mlt and Avelox drug interactions.

What are the common drug interactions of Maxalt-Mlt and Avelox, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Asthenia (weakness)
  3. Bacterial infection
  4. Blood alkaline phosphatase increased
  5. Blood glucose increased
  6. Bone density decreased
  7. Bone disorder
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  10. Colitis (inflammation of colon)

male:

  1. Angiofibroma (small, reddish brown or even flesh-coloured, smooth, shiny, 0.1- to 0.3 cm papules present over the sides of the nose and the medial portions of the cheeks)
  2. Anxiety
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Cellulitis (infection under the skin)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Craniocerebral injury (injury to cranium and brain)
  10. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth)

What are the common drug interactions of Maxalt-Mlt and Avelox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  4. Weight decreased
  5. Activities of daily living impaired
  6. Fatigue (feeling of tiredness)

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Pain in extremity
  3. Pain in jaw
  4. Purulent discharge (discharge that contains pus)
  5. Rib fracture
  6. Tenderness (pain or discomfort when an affected area is touched)
  7. Abdominal pain
  8. Accident at work
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)

60+:

  1. Arrhythmia (irregular heartbeat)
  2. Eye disorder

What are the existing conditions these people have? *

  1. Breast Cancer: 22 people, 73.33%
  2. Ovarian Cancer (cancer of ovary): 21 people, 70.00%
  3. Neoplasm Malignant (cancer tumour): 21 people, 70.00%
  4. Hot Flush (sudden feelings of heat): 21 people, 70.00%
  5. Discomfort: 21 people, 70.00%
  6. Breast Cancer Metastatic: 21 people, 70.00%
  7. Granulocyte Count Decreased: 20 people, 66.67%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 20.00%
  9. Sleep Disorder: 2 people, 6.67%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt-mlt and Avelox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxalt-mlt and Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxalt-mlt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avelox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate and moxifloxacin hydrochloride (the active ingredients of Maxalt-mlt and Avelox, respectively), and Maxalt-mlt and Avelox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: